ASST
New money, same wild ride
Trivium Point Advisory LLC disclosed a new position in Strive (NASDAQ: ASST) worth about $103,000, buying 140,010 shares. For a stock with a beta that basically screams “hold my coffee,” even a modest new institutional bet can catch attention.
Why this matters
This isn’t a mega-fund moving the whole market, but it is another data point that someone with capital thinks the stock deserves a seat at the table. That can matter when you’re trying to figure out whether a name is getting quietly accumulated or just tossed around like a meme-stock dodgeball.
The other noise in the room
The article also notes that Strive’s CFO Benjamin Pham bought 7,900 shares at $8.23 for roughly $65,017, while analysts have been busy playing the “how high can this thing go?” game:
- TD Cowen started coverage with a buy and $26 target
- B. Riley initiated at buy with a $12 target
- Maxim Group trimmed its target to $20 but kept a buy
- Zacks nudged the stock to hold
Big picture
Strive is still the kind of stock that can make your chart look like a ski slope in reverse, so these filings and ratings won’t magically calm things down. But for investors, they do provide one useful clue: more eyes, more opinions, and at least a little fresh capital are circling the name.